Plan: OPEN | Option: Growth | Sailesh Raj Bhan

21 Feb 19 | 12:00 AM

147.81 0.97 (0.66%)

  • Outperforms

    5.83%

    Return (1Y)

    beaten S&P BSE Healthcare TRI by 8.15%

  • Less Volatile

    0.96%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.36%

  • Consistent

    8/12

    Months

    Has beaten Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Scheme Trivia

  • Reliance Pharma Fund (G) fund has topped the 5Y performance in the Equity - Pharma category

  • Reliance Pharma Fund (G) fund has been given the best Risk adjusted performance for the past 5Y in the Equity - Pharma category

  • Reliance Pharma Fund (G) fund has topped the 5Y SIP performance in the Equity - Pharma category

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Reliance Pharma Fund (G), has beaten by 8.15% (CAGR difference)

5.83%

Outperforms

This is Alpha

Performance Chart for Rs

Invested in

Risk

In last 1 year , the volatility of Reliance Pharma Fund (G) is Lower than by -0.36%

0.96%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 8 out of Last 12 Months, i.e 66.67% of the times It beaten its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition